Zota Health Care Ltd. (IN:ZOTA)
:ZOTA
Want to see IN:ZOTA full AI Analyst Report?
ZOTA Stock Chart & Stats
₹1533.20
₹23.30(2.41%)
At close: 4:00 PM EST
₹1533.20
₹23.30(2.41%)
Day’s Range― - ―
52-Week Range₹917.20 - ₹1,740.00
Previous CloseN/A
Volume255.13K
Average Volume (3M)68.23K
Market Cap
₹37.16B
Enterprise Value₹35.88B
Total Cash (Recent Filing)₹63.18M
Total Debt (Recent Filing)₹1.81B
Price to Earnings (P/E)―
Beta1.04
Next Earnings
Aug 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.06%
Share Statistics
EPS (TTM)-16.69
Shares Outstanding30,332,655
10 Day Avg. Volume83,032
30 Day Avg. Volume68,228
Financial Highlights & Ratios
PEG Ratio-5.04
Price to Book (P/B)5.05
Price to Sales (P/S)6.51
P/FCF Ratio-18.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-20.3
Revenue Forecast (FY)₹11.08B
Bulls Say, Bears Say
Bulls Say
Rapid Revenue GrowthSustained top-line acceleration (from single digits to ~81% in 2026) indicates strong commercial traction and market demand across products. Over 2–6 months this provides a larger revenue base to leverage fixed costs, supports scale benefits, and underpins recovery potential if margins stabilize.
Diversified Product & Market FootprintA multi-therapeutic mix combined with both branded and generic offerings across domestic and export channels reduces single-market and single-product reliance. This structural diversification supports revenue durability, portfolio resilience to localized shocks, and cross-market growth opportunities over the medium term.
Moderate Reported LeverageA declining debt-to-equity ratio and a larger equity base on the balance sheet imply room to finance operations or investments without extreme leverage. On a durable basis this gives management financial flexibility to fund growth or refinance obligations while addressing operational profitability gaps.
Bears Say
Sharp Gross Margin CollapseA precipitous fall in gross margin signals structural pressure from pricing, adverse mix, or cost inflation that erodes core unit economics. Persistent low gross margins materially reduce scope to cover fixed costs and are a durable headwind to achieving sustainable profitability even with strong revenue growth.
Persistent Cash BurnConsistent negative operating and free cash flow implies the business is not self-funding and requires external capital to run. Over several quarters this increases refinancing and execution risk, can constrain investment, and raises the likelihood of dilution or higher borrowing costs if operations don't turn cash-positive.
Ongoing Losses & Negative ROESustained operating losses and negative returns on equity indicate the company has not converted revenue growth into shareholder returns. Over the medium term this weakens retained capital, limits reinvestment capacity, and elevates the need for external funding unless operational margins and returns materially improve.
Zota Health Care Ltd. News
ZOTA FAQ
What was Zota Health Care Ltd.’s price range in the past 12 months?
Zota Health Care Ltd. lowest stock price was ₹917.20 and its highest was ₹1740.00 in the past 12 months.
What is Zota Health Care Ltd.’s market cap?
Zota Health Care Ltd.’s market cap is ₹37.16B.
When is Zota Health Care Ltd.’s upcoming earnings report date?
Zota Health Care Ltd.’s upcoming earnings report date is Aug 10, 2026 which is in 57 days.
How were Zota Health Care Ltd.’s earnings last quarter?
Zota Health Care Ltd. released its earnings results on May 22, 2026. The company reported -₹4.4 earnings per share for the quarter, beating the consensus estimate of -₹18.4 by ₹14.
Is Zota Health Care Ltd. overvalued?
According to Wall Street analysts Zota Health Care Ltd.’s price is currently Overvalued.
Does Zota Health Care Ltd. pay dividends?
Zota Health Care Ltd. pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.06%. See more information on Zota Health Care Ltd. dividends here
What is Zota Health Care Ltd.’s EPS estimate?
Zota Health Care Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zota Health Care Ltd. have?
Zota Health Care Ltd. has 30,332,655 shares outstanding.
What happened to Zota Health Care Ltd.’s price movement after its last earnings report?
Zota Health Care Ltd. reported an EPS of -₹4.4 in its last earnings report, beating expectations of -₹18.4. Following the earnings report the stock price went down -1.949%.
Which hedge fund is a major shareholder of Zota Health Care Ltd.?
Currently, no hedge funds are holding shares in IN:ZOTA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Zota Health Care Ltd.
Zota Health Care Limited is an Indian pharmaceutical firm dedicated to the development, manufacturing, and distribution of a broad spectrum of health-related products across India. Its extensive portfolio encompasses generic medications, over-the-counter (OTC) remedies, traditional Ayurvedic formulations, and nutritional supplements (nutraceuticals). The company places a particular emphasis on supplying treatments for various long-term illnesses, including but not limited to heart disease, diabetes, and thyroid conditions. By March 31, 2021, Zota had established a considerable retail network, operating 591 stores under its DAVAINDIA brand name throughout 24 states in India. The company was founded in 1995 and is currently headquartered in Surat, India.
Technical Analysis
Concord Biotech Ltd.
―
Dishman Carbogen Amcis Ltd.
―
Panacea Biotec Limited
―
Supriya Lifescience Limited
―
OneSource Specialty Pharma Limited
―